This story is from the CurrentWire archive. Coverage details reflect the last time it was updated.
Bracco Expands BubbleGen Cell Selection with CD3+ T Cell Isolation Kit
Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development PRINCETON, N.J. — Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™ cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on […]
Financial Post
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Financial Post.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 2 minutes later, on .
Filed under Business · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: Expands BubbleGen Cell Selection (none), Cell Isolation Kit (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.